Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.18%
March 31, 2026 -1.24%
December 31, 2025 -24.17%
September 30, 2025 -24.50%
June 30, 2025 -22.69%
March 31, 2025 -50.09%
December 31, 2024 -21.42%
September 30, 2024 -31.24%
June 30, 2024 -29.92%
March 31, 2024 -6.05%
December 31, 2023 -15.73%
September 30, 2023 -10.75%
June 30, 2023 -1.91%
March 31, 2023 -7.89%
December 31, 2022 8.64%
September 30, 2022 -3.12%
June 30, 2022 5.62%
March 31, 2022 -2.45%
December 31, 2021 -13.01%
September 30, 2021 -24.69%
June 30, 2021 -16.55%
March 31, 2021 22.47%
December 31, 2020 -7.66%
September 30, 2020 0.03%
June 30, 2020 -14.44%
Date Value
March 31, 2020 -19.63%
December 31, 2019 -19.69%
September 30, 2019 -3.42%
June 30, 2019 -4.59%
March 31, 2019 -5.81%
December 31, 2018 -8.52%
September 30, 2018 -19.19%
June 30, 2018 1.16%
March 31, 2018 -37.97%
December 31, 2017 -7.42%
September 30, 2017 -2.80%
June 30, 2017 -32.99%
March 31, 2017 -16.62%
December 31, 2016 -51.88%
September 30, 2016 -34.54%
June 30, 2016 -15.53%
March 31, 2016 -19.47%
December 31, 2015 -29.46%
September 30, 2015 -44.49%
June 30, 2015 -37.72%
March 31, 2015 -17.33%
December 31, 2014 -32.89%
September 30, 2014 -35.68%
June 30, 2014 -35.12%
March 31, 2014 -45.64%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 27.82%
Neogen Corp. -5.34%
QuidelOrtho Corp. -14.74%
Aspira Women's Health, Inc. -118.3%
Biomerica, Inc. -130.9%